NCT03363321 - PF-06741086 Long-term Treatment in Severe Hemophilia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 30, 2018

Primary Completion Date

August 5, 2020

Study Completion Date

August 5, 2020

Conditions

Hemophilia A or B

Interventions

BIOLOGICAL

PF-06741086

PF-06741086 subcutaneous injection

Trial Locations (8)

Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg

Phoenix Pharma (Pty) Ltd, Port Elizabeth

UniversitatsSpital Zurich, Zurich

Klinicki bolnicki centar Zagreb, Zagreb

UC Denver Hemophilia and Thrombosis Center, Aurora

Hospital Dr. Sotero del Rio, Santiago

Centro de Hematologia e Hemoterapia de Campinas- Hemocentro de Campinas, Campinas

Klinika Hematologii i Transplantologii Uniwersyteckie Centrum Kliniczne, Gdansk